Address
Email address
Phone number
Website
Name
Boehringer Ingelheim RCV GmbH & Co KG Eesti filiaal
Registry code
11716380
VAT number
EE101331393
Type
FIL - Branch
Status
Registered
Foundation date
17.09.2009 (15)
Financial year
01.01-31.12
Activity
46461 - Wholesale of medicines and other pharmacy goods
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Lina Valiulienė 13.12.1975 (48) | - | Branch manager | - | |
| Jan Kesler 11.06.1978 (46) | - | Procurator | - |
| 2019 11.06.2020 | 2020 07.06.2021 | 2021 30.06.2022 | 2022 03.07.2023 | |
|---|---|---|---|---|
| Total Revenue | - | - | - | - |
| Net profit (loss) for the period | - | - | - | - |
| Profit Margin | - | - | - | - |
| Current Assets | - | - | - | - |
| Fixed Assets | - | - | - | - |
| Total Assets | - | - | - | - |
| Current Liabilities | - | - | - | - |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | - | - | - | - |
| Employees | - | - | - | - |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 10 485 562.84 € | 564 778.36 € | 152 257.86 € | 17 |
| 2023 Q4 | 10 972 901.68 € | 524 911.32 € | 147 886.37 € | 18 |
| 2023 Q3 | 9 847 293.96 € | 465 253.5 € | 109 183.49 € | 18 |
| 2023 Q2 | 8 942 215.16 € | 518 116.8 € | 211 027.03 € | 17 |
| 2023 Q1 | 10 089 564.75 € | 469 495.57 € | 126 726.03 € | 18 |
| 2022 Q4 | 9 161 825.37 € | 435 011.84 € | 135 348.26 € | 18 |
| 2022 Q3 | 8 939 798.84 € | 402 785.57 € | 102 291.27 € | 18 |
| 2022 Q2 | 8 790 331.26 € | 456 848.29 € | 177 692.67 € | 19 |
| 2022 Q1 | 9 528 757.81 € | 444 032.26 € | 130 032.5 € | 19 |
| 2021 Q4 | 8 808 600.93 € | 1 010 871.17 € | 128 013.54 € | 19 |
| 2021 Q3 | 8 201 410.64 € | 382 522.73 € | 108 643.79 € | 19 |
| 2021 Q2 | 6 444 356.9 € | 356 169.69 € | 153 780.29 € | 19 |
| 2021 Q1 | 8 658 123.49 € | 400 442.3 € | 115 643.93 € | 19 |
| 2020 Q4 | 8 030 732.39 € | 372 349.66 € | 109 608.04 € | 16 |
| 2020 Q3 | 7 291 899.75 € | 300 526.84 € | 90 147.26 € | 18 |
| 2020 Q2 | 7 386 128.2 € | 360 899.49 € | 120 989.88 € | 17 |
| 2020 Q1 | 9 019 531.36 € | 399 121.85 € | 108 368.68 € | 17 |
